Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at

  • January 19, 2022

    Myth vs. Fact: CMS Draft Decision on Alzheimer’s Drugs

    With so much misinformation surrounding the draft National Coverage Determination (NCD) from...

    Read more
  • January 13, 2022

    New Guidance Provides Clinical Recommendations to Reduce Dementia Risk

    Today, Primary Prevention Recommendations to Reduce the Risk of Cognitive Decline...

    Read more
  • January 12, 2022

    Medicare Slams the Door on Alzheimer’s Treatments

    The Centers for Medicare and Medicaid Services (CMS) announced today that it...

    Read more
  • January 10, 2022

    UsAgainstAlzheimer’s Applauds HHS Secretary Becerra for Calling on Medicare to Reexamine its Planned Premium Increase

    Just weeks after UsAgainstAlzheimer’s urged Health and Human Services Secretary Xavier Becerra...

    Read more
  • January 07, 2022

    UsAgainstAlzheimer’s Calls on Medicare to Cover Aduhelm for Alzheimer’s Patients

    study released today shows that the number of adults living with...

    Read more
  • December 27, 2021

    UsAgainstAlzheimer’s Celebrates Federal Government Action Making Risk Reduction for Alzheimer’s and Related Dementias a National Priority

    The United States today made the prevention of Alzheimer’s and related dementias...

    Read more
  • December 26, 2021

    Becerra: Federal Government to Make Alzheimer’s Prevention a National Priority

    UsAgainstAlzheimer’s applauded Health and Human Services Secretary Xavier Becerra, who announced on...

    Read more
  • December 22, 2021

    Letter to Becerra: Historic Medicare Premium Increase Must be Reversed Based on New Data

    UsAgainstAlzheimer’s, a patient advocacy group representing more than six million Alzheimer’s patients...

    Read more
  • December 20, 2021

    Dramatic Price Reduction for Aduhelm Gives Hope to Alzheimer’s Patients

    More patients will soon have access to Aduhelm, the only treatment on...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.